Peter James O'Dwyer

机构：University of Pennsylvania, Philadelphia University · ORCID：0000-0002-9302-4073

发表论文 788 篇 · 总被引 43057 次 · h-index 87

代表论文

• Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E (2026 · JCO Precision Oncology · 被引 2)
• Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial (2026 · Nature Cancer · 被引 1)
• Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2 (2026 · Clinical Cancer Research · 被引 1)
• Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201 (2025 · The Oncologist · 被引 1)
• The Next Frontier in Quantitative Co-Clinical Imaging to Advance Functional Precision Oncology (2026 · Clinical Cancer Research)
• A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131 (2026 · Clinical Colorectal Cancer)